NextGen-O2k Exploitation

From Bioblast
Jump to: navigation, search


NextGen-O2k         K-Regio MitoFit         O2k-Innovation         Houska-Award 2012         K-Regio MitoCom         Bioblast 2012


NextGen-O2k Exploitation

NextGen-O2k

The revolutionary all-in-one instrument to conquer mitochondrial disease.



WP4: Exploitation



Abstract

Preparation for a successful market launch of the NextGen-O2k.


Progress and next steps

2020-05-22: Successful registration of “NextGen-O2k”, “DatLab” and “High-Resolution Respirometry” as EU-trademarks
2020-05-08/15: Our Customer Relations Elf, Carolina Gnaiger, attended a 2-day Intellectual Property Right Webinar on patent and trade mark search.
2020-02-04: Our Mitochondrial Wizard Luiza Daltro Cardoso, PhD went to Japan to meet our distributor and teach him high-resolution respirometry combined with H2O2, mt-membrane potential and ATP production measurements: Distributor engagement Tokyo JP
2020-02-03 The O2k-Installation Qualification / Operational Qualification protocol (abbrev: IQOQ) is available now: MiPNet25.08 O2k-IQOQ protocol
2019-12-20: Started registration process of “NextGen-O2k” as an EU-trademark
2020-10-03: Erich Gnaiger travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor Berthold Japan K.K.
2019-07-01: The first Distributor Meeting took place, see more: Oroboros Distributor Meeting




Links and references